Lynronne-2

General Information


DRACP ID  DRACP00809

Peptide Name   Lynronne-2

Sequence  HLRRINKLLTRIGLYRHAFG

Sequence Length  20

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP Membrane-targeted



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
HepG2 Hepatoblastoma Blastoma Not active up to 128 µg/ml Not available Not available 1

Hemolytic Activity  Human erythrocytes: 20% Hemolysis=500µg/ml; Sheep erythrocytes: 25% Hemolysis=500µg/ml

Normal (non-cancerous) Cytotoxicity  HUVEC: Not active up to 128 µg/ml

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00809

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C111H184N38O24

Absent amino acids  CDEMPQSVW

Common amino acids  LR

Mass  277401

Pl  12.51

Basic residues  7

Acidic residues  0

Hydrophobic residues  8

Net charge  7

Boman Index  -4771

Hydrophobicity  -29

Aliphatic Index  122

Half Life 
  Mammalian: 1.1 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  1490

Absorbance 280nm  78.42

Polar residues  5

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 29214045

Title  The rumen microbiome: an underexplored resource for novel antimicrobial discovery

Doi 10.1038/s41522-017-0042-1

Year  2017

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.